Seizures

Search with Google Search with Bing
Information
Disease name
Seizures
Disease ID
Description
Disease area statistics
Chromosome band
Gene symbol Chromosome Start Stop The number of variant
KARS1 16 75,627,474 75,647,665 8
MECP2 X 154,021,573 154,097,717 8
RARS2 6 87,513,763 87,590,028 8
GTPBP3 19 17,337,555 17,342,022 8
BOLA3 2 74,135,400 74,147,912 8
EARS2 16 23,525,024 23,557,344 8
SCN2A 2 165,239,434 165,392,310 4
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT05823168 Active, not recruiting Seizures and Traumatic Brain Injury Rehabilitation January 1, 2021 December 31, 2026
NCT04244175 Active, not recruiting Phase 2 A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures January 27, 2020 July 2024
NCT04595786 Active, not recruiting N/A The Safety of Intravenous Tranexamic Acid in Patients Undergoing Supratentorial Meningiomas Resection October 30, 2020 February 24, 2023
NCT04686786 Active, not recruiting Phase 2 An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures December 8, 2020 July 2025
NCT02813980 Active, not recruiting Neural Circulatory Control and SUDEP Risk. June 2016 December 2028
NCT04259125 Active, not recruiting Evaluating the Role of Inflammation in Neonatal Epileptogenesis December 15, 2018 November 30, 2024
NCT03529045 Active, not recruiting Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System. February 5, 2018 April 30, 2025
NCT00040326 Completed Phase 3 Early Surgical Intervention to Treat Epilepsy July 2002 November 2007
NCT00041951 Completed Search for Genes Influencing Childhood Absence Epilepsy (CAE) Study December 1998 July 2014
NCT00067210 Completed Phase 2 Reducing Seizure Frequency Using Cooling of the Head and Neck August 11, 2003 May 22, 2007
NCT00088452 Completed Phase 3 Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study July 2004 August 31, 2016
NCT00113815 Completed Phase 3 Topiramate as Adjunctive Therapy in Infants 1-24 Months for the Control of Partial Onset Seizures May 2005 November 2007
NCT00141427 Completed Phase 4 Pregabalin In Partial Seizures: An Open-Label, International, Multicenter Add-On Therapy Trial. November 2004 May 2006
NCT00143130 Completed Phase 3 Pregabalin In Partial Seizures Extension Study April 2005 September 2007
NCT00147030 Completed N/A TOBY (TOtal Body hYpothermia): a Study of Treatment for Perinatal Asphyxia December 2002 August 2008
NCT00162981 Completed Phase 2 Clobazam in Subjects With Lennox-Gastaut Syndrome October 2005 October 2006
NCT06451289 Completed Study on Optic Nerve Sheath Diameter Measurements in Prolonged Pediatric Seizures September 1, 2020 December 1, 2022
NCT00224952 Completed Pathogenesis of Adverse Drug Reactions July 2002 March 2010
NCT00230698 Completed Phase 3 A Study of the Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset Seizure November 1995 August 2002
NCT00231556 Completed Phase 3 A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent Epilepsy July 1999 September 2003
NCT00232596 Completed Phase 3 Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy September 2005 January 2008
NCT00233012 Completed Phase 1 A Study of the Pharmacokinetics, Safety and Tolerability of Topiramate in Infants (Age 1-24 Months) With Refractory Partial-onset Seizures June 2005 October 2007
NCT00235755 Completed Phase 3 Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy December 2005 April 2008
NCT00236418 Completed Phase 3 A Study of the Efficacy and Safety of Topiramate in Epilepsy Patients With Primary Generalized Tonic-clonic Seizures December 1994 December 1996
NCT00236691 Completed Phase 2 A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures. July 1988 December 1990
NCT00236704 Completed Phase 3 A Study of the Efficacy and Safety of Topiramate as "Add on" Treatment in Epilepsy Patients With Primary Generalized Tonic-clonic Seizures March 1994 December 1999
NCT00236717 Completed Phase 3 A Study of the Effectiveness and Safety of Topiramate Compared With a Standard Therapy in Patients Newly Diagnosed With Epilepsy September 1997 November 2000
NCT00236730 Completed Phase 2 A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Difficult to Control Epilepsy June 1988 December 1990
NCT00236743 Completed Phase 3 A Study of the Effectiveness and Safety of Topiramate in the Treatment of Children With Epilepsy June 1994 October 2000
NCT00236756 Completed Phase 3 A Study of the Efficacy and Safety of Topiramate as an add-on Therapy in the Treatment of Epilepsy Patients With Lennox-Gastaut Syndrome August 1993 February 2001
NCT00236847 Completed Phase 2 A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy. December 1989 July 1993
NCT00236860 Completed Phase 2 A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures May 1989 February 1992
NCT00236873 Completed Phase 2 A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures. October 1989 May 1993
NCT00236886 Completed Phase 3 Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients May 1998 June 2000
NCT00266591 Completed Phase 3 A Study of the Efficacy and Safety of Topiramate Treatment in Patients With Epilepsy October 1992 April 1997
NCT00266604 Completed Phase 4 A Study to Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of Epilepsy December 2005 June 2007
NCT00297349 Completed A Study of the Safety of Topiramate Given in Combination With Other Medications in Adults and Children With Seizures November 2003 June 2005
NCT00298246 Completed Clinical and Immunological Investigations of Subtypes of Autism February 22, 2006 March 15, 2017
NCT00318929 Completed N/A Tolerability and Efficacy of Depakote-extended Release in the Elderly April 2006 January 2008
NCT00319501 Completed Phase 3 Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures. January 2006 July 2014
NCT00326612 Completed Phase 2 Intranasal Midazolam Versus Rectal Diazepam for Treatment of Seizures June 2006 December 2008
NCT00345475 Completed UCB Antiepileptic Drugs (AED) Pregnancy Registry (Formerly the Keppra® Pregnancy Registry) December 2004 May 2016
NCT00361010 Completed N/A A Pilot Study of Efficacy and Tolerability of Levetiracetam Monotherapy in Subjects With Childhood Absence Epilepsy December 2006 December 2007
NCT06271096 Completed Early Phase 1 Intramuscular Midazolam Versus Intravenous Diazepam for Acute Seizure in Children November 1, 2019 January 1, 2024
NCT00518713 Completed Phase 3 Clobazam in Patients With Lennox-Gastaut Syndrome August 2007 April 2010
NCT00534378 Completed Phase 1 Phase I Trail for Intramuscular Administration of Midazolam Using An Autoinjector July 2006 December 2006
NCT00616681 Completed N/A Bioequivalency Study of 600 mg Oxcarbazepine Tablets Under Fasting Conditions June 2004 July 2004
NCT00616863 Completed N/A Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed Conditions July 2004 July 2004
NCT00618046 Completed N/A Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed Conditions November 2004 November 2004
NCT00697918 Completed Phase 3 Long Term Effectiveness and Safety Study for RWJ-333369 as Adjunctive Therapy in Korean and Japanese Patients With Partial Onset Seizures March 2008 April 2009
NCT00735527 Completed Phase 3 Nasal Versus Venous Lorazepam for Control of Acute Seizures in Children May 2008 April 2009
NCT00789113 Completed Phase 1/Phase 2 Determination of Absorption and Elimination of Lamotrigine-XR November 2008 January 2011
NCT00826722 Completed N/A Bioequivalency Study of Levetiracetam 1g Under Fasted Conditions June 2007 June 2007
NCT00826787 Completed N/A Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fed Conditions August 2005 August 2005
NCT00826865 Completed N/A Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fasting Conditions August 2005 August 2005
NCT00827320 Completed N/A Bioequivalency Study of Levetiracetam 1g Tablets Under Fed Conditions June 2007 June 2007
NCT00830531 Completed Phase 1 Pilot Study of Bumetanide for Newborn Seizures January 2010 January 2019
NCT00864006 Completed Phase 1 Bioequivalence Study of Divalproex Sodium 125 MG Delayed Release Tablets Under Fasting Conditions October 2006 October 2006
NCT00884052 Completed Phase 1/Phase 2 Pharmacokinetic and Safety Trial of Intravenous Levetiracetam in the Treatment of Neonatal Seizures April 2007 October 2011
NCT00884351 Completed Magnetoencephalography in Absence Seizures April 15, 2009 June 15, 2011
NCT00887861 Completed Phase 2 Efficacy of BGG492 in Individuals With Refractory Partial Seizures Undergoing Inpatient Evaluation for Epilepsy Surgery March 2009 August 2010
NCT01027715 Completed N/A The Impact of Electroencephalographic (EEG) Seizure Treatment in Neonatal Encephalopathy January 2010 December 2015
NCT01030094 Completed A Cross-sectional Study to Investigate the Effect of Topiramate on Bone and Mineral Metabolism in Female Participants With Epilepsy February 2007 April 2009
NCT01236001 Completed Belgian Drug-utilization Study to Evaluate the Use of VIMPAT® as Adjunctive Treatment of Partial Onset Seizures in Subjects Aged 16 and Older September 2010 March 2012
NCT01239212 Completed Phase 1/Phase 2 Dosing of Levetiracetam (Keppra) in Neonates September 2010 July 2011
NCT01261416 Completed Pharmacokinetics of Levetiracetam (Keppra) in Neonates October 2008 July 2010
NCT00001912 Completed Brain Tissue Swelling and Seizure Activity in Inactive Cysticercosis August 10, 1999 April 4, 2012
NCT00007670 Completed Phase 3 Does Gabapentin and Lamotriginel Have Significantly Fewer Side-effects While Providing Equal or Better Seizure Control Than the Current Drug Choice, Carbamazepine, for the Treatment of Seizures in the Elderly. January 1998 March 2003
NCT03534258 Completed Does Use of Rapid Response EEG Impact Clinical Decision Making April 30, 2018 July 31, 2019
NCT03561168 Completed Review of Diagnostic Yield of MRI Brain Results in Children Under Age 3 Years October 12, 2017 June 15, 2018
NCT03656939 Completed A Safety Study For Prevenar 13 Among Chinese Children August 1, 2018 July 31, 2020
NCT03722212 Completed N/A Early Diagnosis of the GLUT1 Deficiency Syndrome With a Blood Based Test September 24, 2018 July 9, 2021
NCT03754582 Completed Phase 2 A Study of Intravenous Perampanel in Japanese Participants With Epilepsy November 27, 2018 December 10, 2019
NCT03892798 Completed Database Of Clinical Data For Individuals With Variants In The IRF2BPL Gene November 27, 2018 May 17, 2024
NCT03209323 Completed N/A Epileptiform EEG Patterns During Induction of General Anaesthesia With Sevoflurane Compared to Those With Propofol January 1, 2007 December 13, 2008
NCT00001666 Completed Transcranial Magnetic Stimulation for the Treatment of Poorly Controlled Partial Epilepsy March 1997 June 2002
NCT03360656 Completed N/A Transnasal Induction of Normothermia in Febrile Stroke Patients January 16, 2018 April 22, 2022
NCT03826056 Completed N/A Neurology Inpatient Clinical Education Trial February 1, 2019 December 7, 2021
NCT03399318 Completed Phase 2 Aggressive Antipyretics for Fever Reduction in CNS Malaria January 7, 2019 December 2, 2022
NCT00004729 Completed N/A Ketogenic Diet for Child Epilepsy and Seizure Control July 1997
NCT01338363 Completed Drug Utilization and Safety Events Among Children Using Esomeprazole, Other Proton Pump Inhibitors or H2-receptor Antagonists May 2011 August 2015
NCT00001149 Completed Monitoring Patients With Uncontrolled Epilepsy November 1975 January 2002
NCT01415362 Completed N/A Closed-loop System Using Transcranial Direct Current Stimulation (tDCS) for Epilepsy July 2011 July 2014
NCT01431326 Completed Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care November 2011 November 2019
NCT01459692 Completed N/A Reduction and Prevention of Seizure Occurrence From Exposure to Auditory Stimulation in Individuals With Neurological Handicaps February 2005 January 2008
NCT05103735 Completed Propofol-remifentanyl Versus Dexmedetomidine in Awake Craniotomy: Impact on Electroclinical Seizure Activity September 15, 2021 October 11, 2021
NCT01515436 Completed N/A The Effect of Music Periodicity on Interictal Epileptiform Discharges February 2004 December 2007
NCT01554683 Completed N/A Seizure Activity in Alzheimer's Disease February 2012 July 1, 2017
NCT01702623 Completed Phase 1 Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fasted Conditions September 2009 September 2009
NCT01703468 Completed Phase 1 Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fed Conditions September 2009 October 2009
NCT01774500 Completed Biomarkers In Seizure To Predict Recurrence and Severe Outcomes January 2013 March 2014
NCT01855178 Completed Pediatric Seizure Movement Bed Alarm October 2010 June 2015
NCT01856335 Completed Early Phase 1 Exercise Education for Adults With Seizure Disorders May 10, 2013 December 7, 2018
NCT01897974 Completed Revisiting Survey Investigating Why Patients Are Not Receiving Home Anti-convulsant Medication Prior to Surgery/or Procedure Involving General Anesthesia June 2013 June 2014
NCT04511676 Completed The Study of Pharmacokinetics of Levetiracetam in Patients Undergoing Intermittent Hemodialysis November 1, 2018 October 10, 2019
NCT04497142 Completed Phase 1/Phase 2 Effect of Perampanel on Peritumoral Hyperexcitability in HGG November 5, 2020 May 16, 2023
NCT02019667 Completed Phase 2 Phase 2 Clinical Trial of SGS-742 Therapy in Succinic Semialdehyde Dehydrogenase Deficiency March 31, 2014 April 3, 2019
NCT04439656 Completed Detecting Absence Seizures Using Eye Tracking July 15, 2020 June 28, 2022
NCT00001192 Completed Neuropsychological Evaluation of Psychiatric and Neurological Patients October 18, 1983 December 20, 2006
NCT04426994 Completed Hypomagnesemia Associated With Proton-Pump Inhibitor Use January 31, 2017 September 30, 2019
NCT02318602 Completed Phase 3 Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder January 8, 2016 June 22, 2017
NCT02324673 Completed Phase 1/Phase 2 Cannabidiol Oral Solution in Pediatric Participants With Treatment-resistant Seizure Disorders April 13, 2015 May 9, 2016
NCT02332174 Completed Phase 1 Pharmacokinetics and Tolerability of Rufinamide in Healthy Chinese Subjects March 2014 June 2014
NCT04325685 Completed N/A The Effect of Supraglottic and Oropharyngeal Decontamination on the Incidence of Ventilator-associated Pneumonia January 1, 2020 November 7, 2023
NCT02385526 Completed Vagus Nerve Stimulation Titration Protocol to Improve Tolerance and Accelerate Adaptation April 28, 2015 October 10, 2016
NCT04323150 Completed N/A The Effect of Closed Suction System on the Incidence of Ventilator-associated Pneumonia. February 1, 2018 December 31, 2020
NCT02431780 Completed N/A A Multicentre Clinical Investigation of a Decision Support Algorithm for Neonatal Seizure Detection February 12, 2015 February 7, 2017
NCT02458820 Completed N/A Prompt Diagnosis and Treatment of Subclinical Seizures After Cardiac Arrest June 2015 January 2019
NCT02544750 Completed Phase 3 An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6) August 31, 2016 June 11, 2021
NCT02544763 Completed Phase 3 A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6) April 6, 2016 February 26, 2019
NCT00001325 Completed Metabolic Abnormalities in Children With Epilepsy April 1992 June 2004
NCT04202159 Completed A Study to Evaluate the Effectiveness of Perampanel as Only Add-on Treatment in Participants With Primary or Secondarily Generalized Tonic-clonic Seizures January 21, 2020 March 31, 2023
NCT02695537 Completed Phase 1 University of Alabama at Birmingham (UAB) Pediatric CBD Program April 2015 February 27, 2019
NCT02700412 Completed Phase 1 University of Alabama at Birmingham (UAB) Adult CBD Program April 2015 August 8, 2019
NCT02761330 Completed N/A Cognitive Recovery After Electroconvulsive Therapy and General Anesthesia April 2016 September 11, 2019
NCT00001366 Completed Mapping the Areas of the Brain Associated With Language in Children With Epilepsy August 1993 September 2002
NCT04141891 Completed N/A Advancing Understanding of Transportation Options December 12, 2019 December 21, 2023
NCT02881957 Completed Phase 2/Phase 3 Hypovitaminosis D in Neurocritical Patients October 10, 2016 October 10, 2018
NCT02897856 Completed Phase 4 Efficacy and Safety of Intramuscular Midazolam Compared to Buccal Midazolam in Pediatric Seizures September 2016 November 2018
NCT04022486 Completed Seizures in Infants Hospitalized in Pediatric Intensive Care Unit for Bronchiolitis April 1, 2018 May 1, 2019
NCT03103425 Completed Evaluation of StatNet Device for Electroencephalogram (EEG) Recordings June 2009 June 1, 2014
NCT05422664 Enrolling by invitation Acute Sympotomatic Seizure Secondary to Autoimmune Encephalitis and Autoimmune-associated Epilepsy January 1, 2018 December 31, 2025
NCT04998123 Not yet recruiting N/A Efficacy of Intersectional Short Pulse Stimulation for Terminating Seizures January 2025 December 2026
NCT05897658 Not yet recruiting Phase 3 Levetiracetam Prophylaxis in Brain Tumor Resection Pilot June 2024 July 2024
NCT06375395 Not yet recruiting N/A Boosting The Intervention Effect of Negative Memory Through tACS Stimulation May 15, 2024 December 31, 2024
NCT06442748 Not yet recruiting Phase 3 Short Versus Long-term Levetiracetam in Brain Tumors June 1, 2024 June 1, 2031
NCT06045676 Not yet recruiting Electrocardiographic Changes Among Epileptic and Non Epileptic Seizures in Children at Sohag University Hospital September 25, 2023 September 25, 2024
NCT05649891 Not yet recruiting N/A Checklists Resuscitation Emergency Department September 2023 March 2024
NCT05140265 Recruiting De-identified UNMH EEG Corpus Database Creation With Fully De-identified Clinical Information October 11, 2021 December 31, 2030
NCT02216500 Recruiting N/A Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy September 2006 October 2031
NCT02552511 Recruiting Epidemiology Study on Neonatal Seizure September 1, 2015 December 30, 2025
NCT02824822 Recruiting Genetic Markers of Cardiovascular Disease in Epilepsy May 2016 December 2029
NCT03233399 Recruiting N/A Modulating Movement Intention Via Cortical Stimulation July 20, 2017 May 2025
NCT03419260 Recruiting Electrographic Seizure Management and Neurobehavioral Outcomes in Critically Ill Children March 13, 2017 January 1, 2027
NCT03478852 Recruiting Investigating Epilepsy: Screening and Evaluation March 28, 2018 July 30, 2027
NCT03492060 Recruiting A Natural History Study of hnRNP-related Disorders June 13, 2018 April 2024
NCT03822741 Recruiting Etiology and Treatment of Neonatal Seizure August 8, 2016 December 30, 2026
NCT03934268 Recruiting A Cohort Study on the Prognosis of Neonatal KCNQ2 Gene-associated Epileptic Encephalopathy January 1, 2017 December 2023
NCT03944447 Recruiting Phase 2 Outcomes Mandate National Integration With Cannabis as Medicine December 1, 2018 December 31, 2025
NCT04076449 Recruiting Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy September 3, 2019 December 31, 2026
NCT04737369 Recruiting Multimodal Neuromonitoring December 1, 2020 December 1, 2025
NCT04770337 Recruiting N/A Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy October 25, 2021 December 2024
NCT05121324 Recruiting Phase 3 Pediatric Dose Optimization for Seizures in Emergency Medical Services August 8, 2022 September 30, 2026
NCT05219617 Recruiting Phase 3 Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults April 28, 2022 June 2026
NCT05339126 Recruiting Phase 2 RNS System LGS Feasibility Study October 4, 2022 May 31, 2027
NCT05594017 Recruiting Early Phase 1 Pharmacological Modulation of Brain Oscillations in Memory Processing August 1, 2019 November 30, 2026
NCT05738226 Recruiting N/A EpiCare@Home Validation Study for Focal Onset Seizures January 23, 2023 December 2023
NCT05761756 Recruiting N/A Oxygen Toxicity: Mechanisms in Humans November 28, 2023 March 2026
NCT05772429 Recruiting Long-Term Follow-Up of a Cohort of Participants Prescribed Epidyolex in France in a Real-life Setting April 17, 2023 March 1, 2025
NCT05851391 Recruiting Phase 2 buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest August 7, 2023 April 30, 2025
NCT05864547 Recruiting Predisposing Factors for Post-stroke Epilepsy May 8, 2023 December 2030
NCT06027749 Recruiting N/A Impact of Capturing Ictal Events With Ultra-long-term Ambulatory EEG Monitoring With Remote EEG Monitoring System. October 13, 2023 June 1, 2024
NCT06038513 Recruiting N/A Transnasal Induction of Normothermia for Neurogenic Fever November 21, 2023 November 2024
NCT06067750 Recruiting Comparison of Narcotrend and Cerebral Function Analysing Monitor in Intensive Care to Monitor Seizures and Deep Sedation June 27, 2023 June 30, 2024
NCT06093490 Recruiting Detecting Absence Seizures Using Hyperventilation and Eye Movement Recordings December 1, 2023 December 1, 2024
NCT06129760 Recruiting N/A Glioblastoma Remote Monitoring and Care - Research Protocol April 30, 2024 January 1, 2027
NCT06426615 Recruiting N/A Connectivity and Neural Signatures of Consciousness in Unresponsive States January 1, 2024 December 31, 2027
NCT04193891 Suspended The Effect of Ketogenic Dietary Therapy on Sleep in Adult Epilepsy February 12, 2020 December 2025
NCT05784805 Suspended N/A Acute Effects of Focused Ultrasound Modulation on EEG Behavior in Status Epilepticus Patients June 24, 2023 March 2024
NCT02349087 Terminated EEG in Resuscitated In-hospital Patients December 2014 December 31, 2020
NCT01974700 Terminated Phase 4 Seizure Prophylaxis in Aneurysm Repair July 2013 February 2016
NCT01721317 Terminated Phase 4 Dose-Optimization, Adjunctive Treatment Study of Ezogabine/Retigabine Immediate Release in Partial-onset Seizures December 19, 2012 June 20, 2013
NCT01496612 Terminated Phase 2 Buspirone Therapy for Localized Epilepsy November 22, 2011 April 19, 2016
NCT01478035 Terminated Phase 4 Study on the Efficacy of Phenytoin in the Prophylaxis of Seizures of Patients With Pneumococcal Meningitis at Least 50 Yrs Old. November 2011 December 2015
NCT00697762 Terminated Phase 3 Effectiveness and Safety Study for RWJ-333369 as Adjunctive Therapy in Korean and Japanese Patients With Partial Onset Seizures October 2007 May 2008
NCT01363154 Terminated N/A Prevention of Photoparoxysmal Abnormalities by Mozart K448 November 2010 February 2013
NCT00439387 Terminated The Role of Serotonin in Seizures February 20, 2007 June 5, 2015
NCT00219479 Terminated Phase 4 Dilantin Levels With Continuous Delivery of Enteral Feedings - A Pilot Study August 1997 December 2007
NCT03790436 Terminated N/A Betaquik as an Adjunct to Dietary Management of Epilepsy in Adults on the Modified Atkins Diet September 14, 2018 December 31, 2021
NCT00563459 Terminated Phase 3 Carisbamate Retention Study (CaReS): Comparative Study on the Long Term Effectiveness, Safety and Tolerability of Carisbamate Compared to Two Other Frequently Prescribed Anti-epileptic Drugs (AEDs) in Patients With Epilepsy. November 2007 April 2010
NCT03954314 Terminated Phase 3 DEPOSITION - Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery September 17, 2019 November 28, 2023
NCT02451618 Terminated Novel Epidermal Recording and Detection of Seizures January 27, 2015
NCT02409433 Terminated Phase 4 Comparative Trial of IV Lacosamide Versus Phenytoin for Seizure Management August 2014 November 2015
NCT01320670 Unknown status Neuroimaging Predictors of Treatment Failure in Adult New-onset Epilepsy June 2011 December 2014
NCT03753035 Unknown status Observance of Anticonvulsant Treatments and Quality of Life of Epileptic Children November 29, 2018 September 30, 2019
NCT00516334 Unknown status Study of Bedside EEG to Evaluate Brain Injury in Premature Newborns May 2006 May 2013
NCT04879147 Unknown status Observational and Diagnostical Study on Transient Allostatic Responses of Thyroid Function After Syncopation and Seizure May 5, 2021 May 13, 2024
NCT04885075 Unknown status Phase 4 Comparing the Efficacy of Intranasal Midazolam Versus Intravenous Diazepam for Control of Seizures in Children May 30, 2021 November 30, 2021
NCT04118829 Unknown status Phase 4 Correlation of Serum Level of Perampanel (PER) Level to Cerebrospinal Fluid (CSF) Levels of PER November 1, 2019 March 2023
NCT02850913 Unknown status Phase 2 Doxycycline for the Treatment of Nodding Syndrome September 5, 2016 August 5, 2020
NCT02661919 Unknown status N/A Assessment of the Emfit Mattress Sensor for Detection and Alarm of Night-time Generalized Tonic-clonic Seizures. October 1, 2019 June 30, 2020
NCT04211233 Unknown status N/A Diagnostic Subdural EEG-electrode And Subdural hEmatoma (DISEASE) December 20, 2019 December 30, 2020
NCT02436616 Unknown status microEEG for Neonatal Apnea, Bradycardia and Desaturation January 2013 July 2016
NCT03369522 Unknown status Development of an Epileptic Seizure Detection Algorithm by Continuous Analysis of the Electrocardiogram December 13, 2017 December 2021
NCT03181945 Unknown status N/A Duration of Anti-convulsant Therapy for Acute Symptomatic Seizure in Acute Encephalitis Syndrome May 1, 2016 February 28, 2019
NCT01126307 Unknown status N/A Study of Verapamil in Refractory Epilepsy June 2010 December 2012
NCT04291716 Unknown status N/A Study to Validate Novel Seizure-Detection Algorithm March 2020 December 2020
NCT03054285 Unknown status Phase 4 Does Short-Term Anti-Seizure Prophylaxis After Traumatic Brain Injury Decrease Seizure Rates? July 1, 2017 April 1, 2021
NCT02298647 Withdrawn Biomarker for Gangliosidosis: BioGM1/BioGM2 (BioGM1/GM2) August 20, 2018 February 28, 2021
NCT04102254 Withdrawn N/A Thalamic Stimulation for Epilepsy Study January 7, 2023 January 10, 2025
NCT01730001 Withdrawn N/A Early Versus Late Intubation Trial in Physician Manned Emergency Medical Services January 1, 2015 March 28, 2017
NCT00465244 Withdrawn Phase 2/Phase 3 Seizure Therapy With Intravenous Levetiracetam and Lorazepam January 2008 May 2010
NCT02054949 Withdrawn N/A Treatment Resistant Epilepsy and N-Acetyl Cysteine April 2013 January 2015
NCT00279851 Withdrawn Blood Sugars in Children With Idiopathic Seizures. February 2006 February 2007
NCT01935908 Withdrawn Phase 4 Seizure Prophylaxis With Levetiracetam in Aneurysmal Subarachnoid Hemorrhage - Pilot Study May 2013 May 2013
HPO alt_id (Human Phenotype Ontology)
HP:0001275
HPO alt_id (Human Phenotype Ontology)
HP:0001303
HPO alt_id (Human Phenotype Ontology)
HP:0002125
HPO alt_id (Human Phenotype Ontology)
HP:0002182
HPO alt_id (Human Phenotype Ontology)
HP:0002279
HPO alt_id (Human Phenotype Ontology)
HP:0002306
HPO alt_id (Human Phenotype Ontology)
HP:0002348
HPO alt_id (Human Phenotype Ontology)
HP:0002391
HPO alt_id (Human Phenotype Ontology)
HP:0002417
HPO alt_id (Human Phenotype Ontology)
HP:0002430
HPO alt_id (Human Phenotype Ontology)
HP:0002431
HPO alt_id (Human Phenotype Ontology)
HP:0002432
HPO alt_id (Human Phenotype Ontology)
HP:0002434
HPO alt_id (Human Phenotype Ontology)
HP:0002437
HPO alt_id (Human Phenotype Ontology)
HP:0002466
HPO alt_id (Human Phenotype Ontology)
HP:0002479
HPO alt_id (Human Phenotype Ontology)
HP:0002794
HPO alt_id (Human Phenotype Ontology)
HP:0006997
HPO alt_id (Human Phenotype Ontology)
HP:0010520
HPO Human Phenotype ID (Human Phenotype Ontology)
HP:0001250
MeSH unique ID (MeSH (Medical Subject Headings))
D012640